Ozama Ismail, Ph.D. is the director, Scientific Programs at the Alzheimer’s Association. In this role, he leads the International Society to Advance Alzheimer's Research and Treatment, also known as ISTAART, and oversees its activities and strategic vision. Dr. Ismail also supports the Association's suite of international scientific conferences and guides its educational programs.

ISTAART carries out virtual and in-person programs for over 10,000 members across 122 countries. The society also provides resources and creates opportunities to help advance the careers of researchers, clinicians and all professionals in the field of Alzheimer’s disease and related dementias. Through its activities, ISTAART aims to connect and support the next generation of dementia professionals and foster international progress in dementia research. 

Dr. Ismail is an award-winning science communicator and podcaster. Further, he is an advocate for improving equity and inclusion and is passionate about raising LGBTQ+ and ethnic minority voices within science and society.

Dr. Ismail holds a Ph.D. in neuroscience from the University College London in collaboration with Eli Lilly & Company. He completed his postdoctoral training at Oregon Health & Science University. He has also carried out scientific research at the Wellcome Sanger Institute, Brunel University, and the University of Hertfordshire.